A Study of Boceprevir in Patients who have HIV and Hepatitis C

Update Il y a 4 ans
Reference: EUCTR2008-004864-38

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to compare the efficacy of boceprevir (PO) in combination with peginterferon alfa-2b (PEG2b) (SC) plus ribavirin weight-based dosing (WBD) PO to therapy with PEG2b plus ribavirin alone in adult subjects coinfected with human immunodeficiency virus (HIV) and previously untreated chronic hepatitis C virius (HCV) genotype 1.


Inclusion criteria

  • Chronic hepatitis C